Genetic and environmental factors in cutaneous malignant melanoma

Biochimie

Volumn 84, Issue 1, 2002, Pages 67-74

  Bressac de Paillerets, Brigitte ^a   Avril, Marie Françoise ^a   Chompret, Agnès ^a   Demenais, Florence ^b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSERM   (France)

Author keywords

Melanoma; Review; Risk factors; Susceptibility

Indexed keywords

MELANOCORTIN 1 RECEPTOR; PROTEIN P14;

CANCER GENETICS; CANCER RISK; ENVIRONMENTAL FACTOR; FAMILY HISTORY; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; GERM LINE; HEREDITY; HIGH RISK POPULATION; HUMAN; MELANOMA; PHENOTYPE; REVIEW; RISK ASSESSMENT; SKIN CANCER; SKIN PIGMENTATION; SUN EXPOSURE; ULTRAVIOLET RADIATION;

EID: 0036252542     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(01)01360-8     Document Type: Article

References (93)

1. The hereditary variant of familial melanoma
2. Genetic Analysis Workshop 7: Summary of the melanoma workshop
3. Interactions between genetic and epidemiological risk factors in cutaneous malignant melanoma in France
4. Melanoma epidemiology
5. Patterns of familial aggregation of three melanoma risk factors: Great number of naevi, light phototype and high degree of sun exposure
6. Cutaneous malignant melanoma
7. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22
8. Molecular definition of a chromosome 9p21 germ-line deletion in a woman with multiple melanomas and a plexiform neurofibroma: Implications for 9p tumor-suppressor gene(s)
9. Homozygous deletions within human chromosome band 9p21 in melanoma
10. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
11. Germline p16 mutations in familial melanoma
12. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
13. INK4 mutations
14. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden)
15. High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families
16. Characterization of ligurian melanoma families and risk of occurrence of other neoplasia
17. CDKN2A mutations in multiple primary melanomas
18. CDKN2A germline mutations in U.K. patients with familial melanoma and multiple primary melanomas
19. Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effect
20. Germline CDKN2A mutations in childhood melanoma
21. Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes
22. Mutation of the CDKN2A 5′ UTR creates an aberrant initiation codon and predisposes to melanoma
23. A deep intronic mutation in CDKN2A is associated with disease in a subset of melanoma pedigrees
24. Haplotype analysis of two recurrent CDKN2A mutations in 10 melanoma families: Evidence for common founders and independent mutations
25. A single genetic origin for the G101W CDKN2A mutation in 20 melanoma- prone families
26. Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effect Genes Chromosomes
27. INK4a binding domain of CDK4 in familial melanoma
28. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France
29. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia
30. Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors
31. Invasive melanoma in Cdk4-targeted mice
32. A new type of p16INK4/MTS1 gene transcript expressed in B-cell malignancies
33. Complex structure and regulation of the P16 (MTS1) locus
34. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
35. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2
36. Interaction between the retinoblastoma protein and the oncoprotein MDM2
37. Human ARF binds E2F1 and inhibits its transcriptional activity
38. Mutations in the INK4a/ARF melanoma susceptibility locus functionally impairs p14ARF
39. A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family
40. A melanoma-associated germline mutation in exon 1beta inactivates p14ARF
41. Tumor spectrum in ARF-deficient mice
42. Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice
43. A familial syndrome with cutaneous malignant melanoma and cerebral astrocytoma
44. Familial aggregation of malignant melanoma/dysplastic naevi and tumours of the nervous system: An original syndrome of tumour proneness
45. Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors
46. CDKN2A germline splicing mutation affecting both p16(ink4) and p14(arf) RNA processing in a melanoma/neurofibroma kindred
47. Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p and evidence for genetic heterogeneity
48. Genetic heterogeneity in familial malignant melanoma
49. Chromosomal mapping of members of the cdc2 family of protein kinases, cdk3, cdk6, PISSLRE, and PITALRE, and a cdk inhibitor, p27Kip1, to regions involved in human cancer
50. Lack of germline CDK6 mutations in familial melanoma
51. CDK inhibitors: Positive and negative regulators of G1-phase progression
52. INK4B is a potential effector of TGF-β-induced cell cycle arrest
53. A cell cycle regulator potentially involved in genesis of many tumor types
54. Genomic structure, expression and mutational analysis of the p15 (MTS2) gene
55. ARF
56. CDKN2A variants in a population-based sample of Queensland families with melanoma
57. Screening of germline mutations in the CDK4, CDKN2C and TP53 genes in familial melanoma: A clinic-based population study
58. Mutation testing in melanoma families: INK4A, CDK4 and INK4D
59. Combined linkage and segregation analysis using regressive models
60. Melanoma Genetics Consortium, Geographical variation in CDKN2A penetrance for melanoma
61. Childhood sun exposure as a risk factor for melanoma: A systematic review of epidemiologic studies
62. Neonatal sunburn and melanoma in mice
63. How much melanoma is caused by sun exposure?
64. Penetrance and expressivity of the chromosome 9 melanoma susceptibility locus (MLM)
65. Incidence of familial melanoma and MLM2 gene
66. Comparison between familial and non familial melanoma in France
67. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: A case-control study
68. Genetic susceptibility to naevi - A twin study
69. Inheritance of nevus number and size in melanoma and dysplastic nevus syndrome kindreds
70. Genetic and epidemiological risk factors for a malignant melanoma- predisposing phenotype: The great number of nevi
71. The atypical-mole syndrome and predisposition to melanoma
72. Gene-covariate interaction between dysplastic nevi and the CDKN2A gene in American melanoma-prone families
73. Sun exposure and melanocytic naevi in young Australian children
74. Constitutional factors and sun exposure in relation to nevi: A population-based cross-sectional study
75. Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lentigines: Multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society
76. Effects of CDKN2A gene, naevus phenotypes and sun-related covariates in French melanoma-prone families
77. Human pigmentation genes and their response to solar UV radiation
78. Participation of the melanocortin-1 receptor in the UV control of pigmentation
79. Genetically determined susceptibility markers in skin cancer and their application to chemoprevention
80. The melanocortin-1 receptor and human pigmentation
81. The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma
82. Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans
83. Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair
84. Melanocortin-1 receptor polymorphisms and risk of melanoma: Is the association explained solely by pigmentation phenotype?
85. Melanocortin-1-receptor gene and sun sensitivity in individuals without red hair
86. Melanocortin-1 receptor variant r151c modifies melanoma risk in Dutch families with melanoma
87. Mc1r genotype modifies risk of melanoma in families segregating cdkn2a mutations
88. Loss of function mutations of the human melanocortin 1 receptor are common and are associated with red hair
89. Functional variation of MC1R alleles from red-haired individuals
90. Two-locus linkage analysis of cutaneous malignant melanoma/dysplastic nevi
91. Further evidence for a locus for cutaneous malignant melanoma-dysplastic nevus (CMM/DN) on chromosome 1p, and evidence for genetic heterogeneity